Investor News Archives - Page 3 of 9

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-08-29

Stockholm, Sweden, August 29, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Martin Ingvar, board member and […]

Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Financial reports, Investor News 2025-08-27

STOCKHOLM – August 27, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver solid sales growth of 54% in the second quarter, […]

Inify Laboratories deliver diagnostics for its first patient case in the UK in collaboration with Parkside Frimley

Investor News 2025-06-26

STOCKHOLM – June 26, 2025 – Inify Laboratories, an ultra-modern laboratory service that provides cancer diagnostics within pathology, is proud to announce a significant milestone with the successful processing of […]

Inify Laboratories AB (publ) – summary of Annual General Meeting

Annual General Meeting, Investor News 2025-05-21

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting on May 20, 2025. A total of 44,461,934 shares were represented at the Annual General Meeting, corresponding […]

Inify Laboratories: Continued strong growth – construction and establishment in the UK

Financial reports, Investor News 2025-04-30

STOCKHOLM – April 30, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continued to deliver sales growth and positive margins in Sweden, alongside steady […]

Inify Laboratories – Annual Report 2024

Annual reports, Financial reports, Investor News 2025-04-16

Stockholm – April 16, 2025 – Inify Laboratories, a unique laboratory service provider within pathology and cancer diagnostics, presents its Annual Report for the fiscal year ended December 31, 2024. […]

Inify Laboratories – notice of Annual General Meeting on May 20, 2025

Annual General Meeting, Investor News 2025-04-16

Stockholm – April 16, 2025 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Annual General Meeting on May […]

Panel talk about Inify’s fourth quarter 2024

Investor News 2025-02-28

Inify Laboratories continues to strengthen its position in the diagnostics market, achieving significant growth and expanding its reach. In Q4 2024, sales increased by 60% compared to the previous quarter […]

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Financial reports, Investor News 2025-02-26

STOCKHOLM – February 26, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, saw sales grow by 60% compared to the previous quarter, and 472% […]

Inify Laboratories – New share capital registered

Investor News 2025-02-14

Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 12 February 2025 regarding the resolution to issue 30,202,366 new shares in a private […]

Inify Laboratories – mandatory notification of trade

Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Inify Laboratories deliver diagnostics for its first patient case in the UK in collaboration with Parkside Frimley

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories: Continued strong growth – construction and establishment in the UK

Inify Laboratories – Annual Report 2024

Inify Laboratories – notice of Annual General Meeting on May 20, 2025

Panel talk about Inify’s fourth quarter 2024

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Inify Laboratories – New share capital registered

Our services

Inify Laboratories

For Investors

Contact us

Social media